Skip to content
healthcare.dev
Get a free key

Cetirizine Hydrochloride Tablets, 5 mg

NDC 25000-219, Cetirizine Hydrochloride, tablet, from MARKSANS PHARMA LIMITED.

Product NDC
25000-219
Status
Listed
Labeler
MARKSANS PHARMA LIMITED
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA078933
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/25000-219 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CETIRIZINE HYDROCHLORIDE5 mg/1

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
25000-219-03250000219031 BOTTLE in 1 CARTON (25000-219-03) / 30 TABLET in 1 BOTTLE
25000-219-08250000219081 BOTTLE in 1 CARTON (25000-219-08) / 100 TABLET in 1 BOTTLE
25000-219-14250000219141000 TABLET in 1 BOTTLE (25000-219-14)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 25000-219 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/25000-219 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 25000-219. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.